Publications

5674 Results

Androgen deprivation and four courses fixed-schedule suramin treatment in patients with newly diagnosed metastatic prostate cancer: a Southwest Oncology Group study

Authors
MHA Hussain;EI Fisher;DP Petrylak;J O'Connor;DP Wood;EJ Small;MA Eisenberger;ED Crawford
Journal / Conference
Journal of Clinical Oncology 18(5):1043-1049
Year
2000
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9343

Maintenance Bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group study

Authors
DL Lamm;BA Blumenstein;JD Crissman;JE Montie;JE Gottesman;BA Lowe;MF Sarosdy;RD Bohl;HB Grossman;TM Beck;JT Leimert;ED Crawford
Journal / Conference
Journal of Urology 163:124-1129
Year
2000
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8507

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation thereapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix

Authors
WA Peters III;PY Liu;RJ Barrett;RJ Stock;BJ Monk;JS Berek;L Souhami;P Grigsby;W Gordon Jr;DS Alberts
Journal / Conference
Journal of Clinical Oncology 18(8):1606-1613
Year
2000
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12)

Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group study

Authors
SK WIlliamson;D Lew;GJ Miller;SP Balcerzak;LH Baker;ED Crawford
Journal / Conference
Cancer 88(5):1159-1165
Year
2000
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8925

A phase II trial of topotecan in esophageal carcinoma: A Southwest Oncology Group study (SWOG-9339)

Authors
JS Macdonald;JL Jacobson;SJ Ketchel;G Weiss;S Taylor;G Mills;JP Kuebler;S Rivkin;M Conrad
Journal / Conference
Investigational New Drugs 18:199-202
Year
2000
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9339

A phase II trial of etoposide, leucovorin, 5-FU, and interferon alpha 2b (ELFI) + G-CSF for patients with pancreatic adenocarcinoma: A Southwest Oncology Group study (SWOG-9413)

Authors
JS Macdonald;JL Jacobson;M Modiano;DF Moore Jr;DR Gandara;LE Schroder;RA Chapman
Journal / Conference
Investigational New Drugs 18:269-273
Year
2000
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9413

Alterations in exon 4 of the p53 gene in gastric carcinoma

Authors
T Shepherd;D Tolbert;J Benedetti;J Macdonald;G Stemmerman;J Wiest;G DeVoe;MA Miller;J Wang;A Noffsinger;C Fenoglio-Preiser
Journal / Conference
Gastroenterology 118:1039-1044
Year
2000
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

A Southwest Oncology Group study of paclitaxel and carboplatin for advanced transitional cell carcinoma: The importance of survival as a clinical trial endpoint

Authors
EJ Small;D Lew;BG Redman;DP Petrylak;N Hammond;HM Gross;JA Eastham;ED Crawford
Journal / Conference
Journal of Clinical Oncology 18(13):2537-2544
Year
2000
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9457

Interferon alfa consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low -grade non-hodgkin's lymphoma: results of theSouthwest Oncology Group randomized phase III study 8809

Authors
RI Fisher;BW Dana;M LeBlanc;C Kjeldsberg;JD Forman;JM Unger;SP Balcerzak;ER Gaynor;V Roy;T Miller
Journal / Conference
Journal of Clinical Oncology 18(10):2010-2016
Year
2000
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8809

Behavioral science research in the cooperative group setting: the Southwest Oncology Group Experience

Authors
CC Gotay;CM Moinpour;S Moody-Thomas;ER Gritz;KS Albain;E DeAntoni;L Hansen;PA Ganz
Journal / Conference
Journal of the National Cancer Institute 92(17):1381-1387
Year
2000
Research Committee(s)
Brain, Breast, Cancer Control, Gastrointestinal, Genitourinary, Head and Neck, and Lymphoma
Study Number(s)
SWOG-8807, SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817), SWOG-9021 (INT-0124) (BTCG-9021) (RTOG-9021), SWOG-9045, SWOG-9208, SWOG-9217, SWOG-9235, SWOG-9248, SWOG-9418, S9632, S9832, S9916